Keryx Biopharmaceuticals

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products geared towards addressing unmet needs and providing unique and meaningful advantages to patients with renal disease and their healthcare providers. Patients have been and continue to be at the center of our 16-year corporate history.
Type
Public
HQ
New York, US
Employees
184 (est)
Keryx Biopharmaceuticals has headquartered in New York, US

Keryx Biopharmaceuticals Locations

New York, US
Boston, US

Keryx Biopharmaceuticals Metrics

Keryx Biopharmaceuticals Summary

Market capitalization

$615 M

Closing share price

$5.67
Keryx Biopharmaceuticals's latest market capitalization is $615 M.

Keryx Biopharmaceuticals Market Value History

Keryx Biopharmaceuticals Company Life

You may also be interested in